Cargando…

Expression of HIF-1α is a predictive marker of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer

Platinum-based, arterial infusion chemotherapy as a neoadjuvant chemotherapy (NACT) followed by hysterectomy may be efficient for the treatment of locally advanced cervical cancer and improve prognosis. It is important to predict whether the NACT would be effective before it is launched. Hypoxia ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Bin, Ma, Quan-Fu, Tan, Wen-Fu, Cai, Hong-Ning, Li, Yan-Li, Zhou, Zhi-Gang, Dai, Xuan, Zhu, Fa-Xia, Xiong, Yu-Jing, Xu, Meng, Guo, Yu-Lin, Gao, Han, Hu, Jun-Bo, Wu, Xu-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285839/ https://www.ncbi.nlm.nih.gov/pubmed/32566011 http://dx.doi.org/10.3892/ol.2020.11596

Ejemplares similares

HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Zhang, Jing, et al.
Publicado: (2020)

Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1α expression
por: Li, Ning, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for locally invasive cervical cancer in pregnancy: two case reports
por: Li, Ming-Zhu, et al.
Publicado: (2019)

Association Between HIF-1 Alpha Gene Polymorphisms and Response in Patients Undergoing Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
por: Chen, Qing, et al.
Publicado: (2016)

Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation
por: Fu, Zhuo, et al.
Publicado: (2021)

Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy
por: Wu, Zhen-Feng, et al.
Publicado: (2015)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Clinicopathological risk factors for recurrence after neoadjuvant chemotherapy and radical hysterectomy in cervical cancer
por: Wang, Huali, et al.
Publicado: (2013)

Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer
por: Zhao, Ke, et al.
Publicado: (2023)

CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer
por: Lin, Yun, et al.
Publicado: (2021)

Neoadjuvant chemotherapy for locally advanced cervical cancer
por: Iwata, Takashi, et al.
Publicado: (2016)

The Bidirectional Regulation between MYL5 and HIF-1α Promotes Cervical Carcinoma Metastasis
por: Zhang, Lan, et al.
Publicado: (2017)

Perioperative Complications and Safety Evaluation of Robot-Assisted Radical Hysterectomy of Cervical Cancer After Neoadjuvant Chemotherapy
por: Chang, Wei-Fu, et al.
Publicado: (2020)

HIF-1α Polymorphism in the Susceptibility of Cervical Spondylotic Myelopathy and Its Outcome after Anterior Cervical Corpectomy and Fusion Treatment
por: Wang, Zhan-Chao, et al.
Publicado: (2014)

HIF-1α and HIF-2α induced angiogenesis in gastrointestinal vascular malformation and reversed by thalidomide
por: Feng, Nan, et al.
Publicado: (2016)

Expression of HIF-1α and HIF-2α correlates to biological and clinical significance in papillary thyroid carcinoma
por: Liu, Yan-Mei, et al.
Publicado: (2016)

RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells
por: Chen, Junying, et al.
Publicado: (2021)

Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer
por: Li, Jing, et al.
Publicado: (2023)

Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer
por: Yu, Xiao-Li, et al.
Publicado: (2021)

Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical Cancer Patients Effectively Improves Immune Function
por: Liu, Mo, et al.
Publicado: (2022)

Markers Associated With Tumor Recurrence in Patients With Breast Cancer Achieving a Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Xie, Li-Yun, et al.
Publicado: (2022)

HIF-1α Regulates the Progression of Cervical Cancer by Targeting YAP/TAZ
por: Abudoukerimu, Azierguli, et al.
Publicado: (2022)

Honokiol improves depression-like behaviors in rats by HIF-1α- VEGF signaling pathway activation
por: Fan, Xiao-Xu, et al.
Publicado: (2022)

Adjuvant chemotherapy after surgery can improve clinical outcomes for patients with IB2-IIB cervical cancer with neoadjuvant chemotherapy followed by radical surgery
por: Sun, Haiying, et al.
Publicado: (2018)

HIF-1α-BNIP3-mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury
por: Fu, Zong-Jie, et al.
Publicado: (2020)

The therapeutic role of Jingchuan tablet on ischaemic cerebral stroke via the HIF-1α/EPO/VEGFA signalling pathway
por: Zhang, Yan, et al.
Publicado: (2022)

Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis
por: Gong, Yuanyuan, et al.
Publicado: (2019)

Implanted markers prior to neoadjuvant chemotherapy: preliminary report
por: Allan for the Dartford Breast Care Team, DM
Publicado: (2000)

HIF-1α protects against oxidative stress by directly targeting mitochondria
por: Li, Hong-Sheng, et al.
Publicado: (2019)

Wogonin inhibits multiple myeloma-stimulated angiogenesis via c-Myc/VHL/HIF-1α signaling axis
por: Fu, Rong, et al.
Publicado: (2015)

HIF-1α activates hypoxia-induced BCL-9 expression in human colorectal cancer cells
por: Tan, Zhen, et al.
Publicado: (2016)

Cobalt chloride inhibits tumor formation in osteosarcoma cells through upregulation of HIF-1α
por: ZHANG, BO, et al.
Publicado: (2013)

HIF-1α and HIF-2α: Siblings in Promoting Angiogenesis of Residual Hepatocellular Carcinoma after High-Intensity Focused Ultrasound Ablation
por: Wu, Lun, et al.
Publicado: (2014)

The Efficacy and Response Predictors of Platinum-Based Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer
por: Huang, Yuhui, et al.
Publicado: (2020)

Could the Extent of Lymphadenectomy Be Modified by Neoadjuvant Chemotherapy in Cervical Cancer? A Large-Scale Retrospective Study
por: Hu, Ting, et al.
Publicado: (2015)

HIF-1α Negatively Regulates Irisin Expression Which Involves in Muscle Atrophy Induced by Hypoxia
por: Liu, Shiqiang, et al.
Publicado: (2022)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

Neoadjuvant chemotherapy endows CD9 with prognostic value that differs between tumor and stromal areas in patients with pancreatic cancer
por: Han, Xuan, et al.
Publicado: (2022)

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
por: Schito, Luana, et al.
Publicado: (2020)

Expression of HIF-2α and VEGF in Cervical Squamous Cell Carcinoma and Its Clinical Significance
por: Zhang, Lixia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g4fd8e8pelu6mvjkb2c41ufp43